Overview
- Moderna shares rose roughly 9% to 12% in Monday premarket trading after health officials reported a mildly positive Andes hantavirus case tied to the MV Hondius.
- The U.S. Department of Health and Human Services said 17 American passengers are being flown home, with two traveling in biocontainment and one showing mild symptoms.
- The World Health Organization reported eight cases, including five confirmed hantavirus infections and three deaths, and said the broader public-health risk is low.
- Moderna said it has ongoing preclinical hantavirus research with the U.S. Army’s infectious-disease institute and Korea University, and noted the work began before the cruise-ship cases.
- Evercore ISI told clients the stock move looks driven by sentiment and sees little revenue from hantavirus, even as Inovio, Novavax, and Emergent Biosolutions also gained in early trading.